MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
-3.99%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$310M
AUM Growth
+$310M
(-13%)
Cap. Flow
-$685K
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
99.09%
Holding
13
New
2
Increased
–
Reduced
2
Closed
1
Top Buys
| 1 |
MacroGenics
MGNX
|
$48.9M |
| 2 |
Sangamo Therapeutics
SGMO
|
$312K |
Top Sells
| 1 |
Pacira BioSciences
PCRX
|
$41.6M |
| 2 |
ZLCS
ZALICUS INC COM NEW
ZLCS
|
$6.68M |
| 3 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$1.53M |
Sector Composition
| 1 | Healthcare | 49.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PETX
1
DELISTED
Aratana Therapeutics, Inc.
PETX
| $83.1M | 26.84% | 4,351,048 | – | – |
|
|
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $62.9M | 20.3% | 2,441,344 | – | – |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $59.9M | 19.35% | 2,880,485 | – | – |
|
|
4
MacroGenics
MGNX
$112M
| $48.9M | 15.78% | +1,780,955 | New | +$48.9M |
|
5
Altimmune
ALT
$338M
| $11.8M | 3.81% | 6,347,614 | – | – |
|
6
Verastem
VSTM
$569M
| $11.8M | 3.8% | 1,033,324 | – | – |
|
|
KBIO
7
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $11.6M | 3.76% | 2,632,928 | – | – |
|
|
HSTO
8
DELISTED
Histogen Inc. Common Stock
HSTO
| $7.69M | 2.48% | 1,192,080 | – | – |
|
|
9
Pacira BioSciences
PCRX
$1.2B
| $5.75M | 1.86% | 100,000 -724,255 | -88% | -$41.6M |
|
|
ETRM
10
DELISTED
EnteroMedics Inc.
ETRM
| $3.41M | 1.1% | 1,669,753 | – | – |
|
|
AVEO
11
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.51M | 0.81% | 1,372,118 -836,843 | -38% | -$1.53M |
|
|
12
Sangamo Therapeutics
SGMO
$157M
| $312K | 0.1% | +22,487 | New | +$312K |
|
|
ZLCS
13
DELISTED
ZALICUS INC COM NEW
ZLCS
| – | – | -5,566,980 | Closed | -$6.68M |
|